Displaying drugs 701 - 702 of 702 in total
Lobeglitazone
Lobeglitazone is an antidiabetic medication from the thiazolidinedione class of drugs. It primarily functions as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated Receptors (PPAR) gamma within fat cells. By activating PPAR-gamma and promoting the binding of insulin at fat cells, lobeglitazone thereby has been shown to reduce blood...
Experimental
Matched Description: … been shown to reduce blood sugar levels, lower hemoglobain A1C (HbA1C) levels, and improve lipid and ... Lobeglitazone was approved by the Ministry of Food and Drug Safety (South Korea) in 2013, and is being ... By activating PPAR-gamma and promoting the binding of insulin at fat cells, lobeglitazone thereby has …
Matched Categories: … Sulfur Compounds ... Alimentary Tract and Metabolism ... metformin and lobeglitazone …
Matched Categories: … Sulfur Compounds ... Alimentary Tract and Metabolism ... metformin and lobeglitazone …
Avasimibe
Investigational
Matched Categories: … Sulfur Compounds ... Metabolic Side Effects of Drugs and Substances …
Displaying drugs 701 - 702 of 702 in total